Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression.

Regulation of c-Myc ubiquitination controls chronic myelogenous leukemia initiation and progression.
复制标题

DOI:
10.1016/j.ccr.2013.01.025
复制
发表时间:
2013-03-18
期刊:
影响因子:
50.3
通讯作者:
Aifantis I
Aifantis I
中科院分区:
医学1区
文献类型:
--
作者:
Reavie L;Buckley SM;Loizou E;Takeishi S;Aranda-Orgilles B;Ndiaye-Lobry D;Abdel-Wahab O;Ibrahim S;Nakayama KI;Aifantis I

文献摘要

参考文献

被引文献

相似文献

白血病起始细胞(LIC)功能调控的分子机制具有重要的临床意义。我们使用慢性粒细胞白血病(CML)作为LIC依赖性恶性肿瘤的模型,并确定泛素连接酶Fbw 7及其底物c-Myc作为LIC稳态调节剂之间的相互作用。Fbw 7的缺失导致c-Myc过表达,p53依赖性LIC特异性凋亡和最终抑制肿瘤进展。c-Myc蛋白水平的降低或p53反应的减弱可挽救LIC活性和疾病进展。进一步的实验表明,Fbw 7表达是人类CML LIC存活和维持所必需的。这些研究确定了泛素连接酶:底物对调节LIC活性,表明靶向Fbw 7:c-Myc轴是难治性CML的有吸引力的治疗靶点。
The molecular mechanisms regulating leukemia-initiating cell (LIC) function are of important clinical significance. We use chronic myelogenous leukemia (CML), as a model of LIC-dependent malignancy and identify the interaction between the ubiquitin ligase Fbw7 and its substrate c-Myc as a regulator of LIC homeostasis. Deletion of Fbw7 leads to c-Myc overexpression, p53-dependent LIC-specific apoptosis and the eventual inhibition of tumor progression. Decrease of either c-Myc protein levels or attenuation of the p53 response rescues LIC activity and disease progression. Further experiments showed that Fbw7 expression is required for survival and maintenance of human CML LIC. These studies identify a ubiquitin ligase:substrate pair regulating LIC activity, suggesting that targeting of the Fbw7:c-Myc axis is an attractive therapy target in refractory CML.
DOI: 10.1038/nbt.1645
发表时间: 2010-07
影响因子: 46.9
作者:
通讯作者: --
DOI: 10.1056/nejmoa040258
发表时间: 2004-08-12
影响因子: 158.5
作者:
Jamieson, CHM;Ailles, LE;Weissman, IL
通讯作者: Weissman, IL
DOI: 10.1038/leu.2009.38
发表时间: 2009-06-01
期刊: LEUKEMIA
影响因子: 11.4
作者:
Hochhaus, A.;O'Brien, S. G.;Larson, R. A.
通讯作者: Larson, R. A.
DOI: 10.1038/nbt.1646
发表时间: 2010-07
影响因子: 46.9
作者:
通讯作者: --
DOI: 10.1016/j.cell.2011.08.017
发表时间: 2011-09-16
期刊: Cell
影响因子: 64.5
作者:
Delmore JE;Issa GC;Lemieux ME;Rahl PB;Shi J;Jacobs HM;Kastritis E;Gilpatrick T;Paranal RM;Qi J;Chesi M;Schinzel AC;McKeown MR;Heffernan TP;Vakoc CR;Bergsagel PL;Ghobrial IM;Richardson PG;Young RA;Hahn WC;Anderson KC;Kung AL;Bradner JE;Mitsiades CS
通讯作者: Mitsiades CS